Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 7/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CDC14B | O60729 | 1/20 | 0.31 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24255857 | 0.96 | ALDH1A1 (0.34) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL24255503 | 0.94 | ALDH1A1 (0.34) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL24256084 | 0.89 | ALDH1A1 (0.34) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL23168915 | 0.88 | CDC14B (0.36) | MAPTCDC14BCDC14A | |
| SCHEMBL26312992 | 0.88 | POLB (0.32) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL24255653 | 0.88 | ALDH1A1 (0.34) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL24256897 | 0.87 | ALDH1A1 (0.41) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL25802795 | 0.87 | ALDH1A1 (0.41) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL24255851 | 0.86 | ALDH1A1 (0.38) | ALDH1A1POLBKDM4EMAPTTSHR | |
| SCHEMBL24255854 | 0.86 | ALDH1A1 (0.38) | ALDH1A1POLBKDM4EMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337529-A1 | ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337529-A1 | ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | LT MATERIALS CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| WO-2022035097-A1 | ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, ORC3 | ALDH1A1 412/4885POLB 1189/4885KDM4E 2416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.